Berkshire buys Teva, bites more Apple, feels IBM blues

(Reuters) - Warren Buffett’s Berkshire Hathaway Inc (BRKa.N) on Wednesday said it has taken a new stake in Teva Pharmaceutical Industries Ltd (TEVA.TA), significantly boosted its holdings of Apple Inc (AAPL.O) and has nearly shed a less successful investment in IBM Corp (IBM.N).

    In a regulatory filing detailing its U.S.-listed stock holdings as of Dec. 31, Berkshire reported owning about 18.9 million of the American depositary receipts in Teva, one of the world’s largest generic drug makers, worth about $358 million.

    Teva’s share price rose more than 10 percent after Berkshire reported its ownership stake.

    Berkshire also reported a 23 percent increase since the end of September in its Apple stake, to about 165.3 million shares, and a 94.5 percent decline in its stake in International Business Machines Corp, to 2.05 million shares.

    Reporting by Jonathan Stempel in New York; Editing by Leslie Adler

    Share this article

    About author

    Super User

    Email This email address is being protected from spambots. You need JavaScript enabled to view it.


    Quas mattis tenetur illo suscipit, eleifend praesentium impedit!
    We use cookies to improve our website. By continuing to use this website, you are giving consent to cookies being used. More details…